Loading...

Heat Biologics, Inc.

HTBXAMEX
Healthcare
Biotechnology
$2.38
$0.010(0.42%)

Heat Biologics, Inc. HTBX Peers

See (HTBX) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HTBX$2.38+0.42%61.1M-2.07-$1.15N/A
VRTX$469.45+2.10%117.7B-120.34-$3.81N/A
REGN$558.50+2.95%57.9B13.86$39.36+0.32%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$325.03+1.40%41.8B-152.63-$2.10N/A
ARGX$572.98+1.49%34.6B34.56$16.38N/A
BNTX$110.65+0.57%26.2B-28.97-$3.76N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$36.03+1.24%20B14.55$2.45+2.99%
SMMT$26.55+1.34%19.6B-77.47-$0.34N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HTBX vs VRTX Comparison

HTBX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HTBX stands at 61.1M. In comparison, VRTX has a market cap of 117.7B. Regarding current trading prices, HTBX is priced at $2.38, while VRTX trades at $469.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HTBX currently has a P/E ratio of -2.07, whereas VRTX's P/E ratio is -120.34. In terms of profitability, HTBX's ROE is -0.31%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, HTBX is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for HTBX.

Stock Price Comparison

Loading...

Frequently Asked Questions

;